Just about. New cases have dropped and are still dropping, and they've had a very low mortality rate. Also, and interestingly, they have very few serious cases.
.....
It looks like norwegian ski-tourists in Austria did much the same. According to this story, half the initial cases were traced back to a specific bartender in Austria who has a norwegian-sounding name:
https://www.aftenposten.no/verden/i/9vdVnM/5-mars-begynte-varslene-om-koronasmittede-skiturister-aa-renne-inn-det-tok-ti-dager-foer-oesterrike-stengte-skiheisene
I wonder if they are running out of tests. Only those who appear to need hospitalization are tested now.
At least you don't cater to the Popper nonsense that scientists are primarily trying to disprove their own theories.
Dust masks would make a nice substitute. I'm not the first one to think of it though, I just checked my usual woodworking sources and they are all sold out.Me either. Like I said, just a passing thought.
I don't know if I have any tee shirts packed away that would make for an appropriate test. I've never been much for tee shirts, and I don't think I have anything which would fit the heavy duty, two-ply description.
As is made very clear by the chart itself.Yes, pandemics look extremely small when they have only just begun, don't they?
(continued)
....If we lived in a just world, I - along with possibly millions of others - would demand criminal sanctions against Xi and Trump.
Xi? Not for being responsible for the initial failures in Wuhan (though those failures alone make him a criminal), but for not doing what was so obviously needed after SARS ... close the "wet markets", eliminate the eating of "wildlife", prepare adequately for the next SARS.
....
(to be continued)
uumm, what? Has CV-19 been linked to eating wild life? I thought that was eliminated early on?
uumm, what? Has CV-19 been linked to eating wild life? I thought that was eliminated early on?
Yes, we appear to be headed for a global recession. I will be surprised if we recover in less than 2 years.My great fear of the moment is that I don't see a path to normalcy from here.
Yes, someday schools will be open and I can go to restaurants again, and unemployment will be back to normal, but I don't see how we get from here to there in weeks, or even months, and if we don't get there in months, the economic fallout will last years.
Think of it from someone working in a shop, then it makes a lot of sense.Yesterday, the Washington Post had an article about the latest mitigation idea: strictly limit the number of people allowed in a grocery store at one time. I'm trying to figure out how this will help. Yes, with a limited amount of people in the store, they will be more spread out than if everyone was let in. But what about the people who will be waiting to get in? Are they going to also be spread out or will they be crammed together more tightly than if they were shopping? And won't they potentially be crammed together for a far longer time than if they were in the store? OK, maybe not, because the people who manage to get into the store will be incentivized to buy as much of everything that they can to preclude risking having to stand in line for hours the next time they need to shop, so I would expect the stores to quickly run out of just about everything.
Think of it from someone working in a shop, then it makes a lot of sense.
a vaccine cannot be developed and deployed for at least a year
It is expected that a COVID-19 vaccine will take 12 to 18 months to develop and manufacture, and even then it may not be effective.
There are now at least a half-dozen candidates, including live viruses, recombinant protein subunits, and nucleic acids that may ultimately offer promise as preventive vaccines against COVID-19. However, each of these vaccines may require additional manufacturing steps and formal toxicology testing before submitting a regulatory package to national regulatory agencies and be able to commence the clinical development, first with phase 1 clinical trials for safety and immunogenicity, and later, phase 2 and phase 3 trials for both safety and efficacy.